Summary

This document provides an overview of basic immunology, covering natural and acquired immunity, types of immune responses, immunologically mediated diseases, and immunodeficiency diseases. It also touches on diagnostic tests and the classification of different immunological diseases.

Full Transcript

Basic Immunology Introduction Natural immunity  Consists of various barriers  1st line of defense  No memory  nonspecific Acquired immunity  Humoral and cell mediated immunity  Stimulation by foreign substances  Specific receptors on lymphocytes and presentation by MQ  Retain memory. The...

Basic Immunology Introduction Natural immunity  Consists of various barriers  1st line of defense  No memory  nonspecific Acquired immunity  Humoral and cell mediated immunity  Stimulation by foreign substances  Specific receptors on lymphocytes and presentation by MQ  Retain memory. The Immune system : consists of 1. Central organs (BM, Thymus) 2. Peripheral organs 3. Cells of Immune system: - Granulocyte (50-70%) - Lymphocyte (30-45%) - Mononuclear Phagocytic (3-8%). Types of Immune Responses:  Humoral ( Antibody mediated) - Neutralization - Opsonisation - Complement fixation  Cell mediated Response - Through Direct contact between Ag and Tc cells. Immunologically mediated Diseases Reaction to self Ag auto-immune Ds. Exaggerated IR producing damage –> hyper-sensitivity Ds. Inadequate IR  Immuno-deficiency Ds. Hyper-sensitivity allergic ds:  1. 2. 3. 4. There 4 types of hypersensitivity reactions: Type I: Anaphylaxis and Atopy (IgE) as drug allergy Type II: Cytotoxic (IgM, IgG) as transfusion reaction Type III: Immune complex ( IgM, IgG) as GN Type IV : Cell mediated by T-lymphocytes ( as TB and contact dermatitis) Type I: Anaphylaxis and Atopy (IgE) as drug allergy Diagnostic tests for immediate hypersensitivity include:  skin (prick and intradermal) tests  measurement of total IgE and specific IgE antibodies against the suspected allergens by ELISA. 1  There appears to be a genetic predisposition for atopic diseases and there is evidence for HLA (A2) association. Type II: Cytotoxic (IgM, IgG) as transfusion reaction  Detection of circulating antibody against the tissues involved ( eg Coomb's test).  The presence of antibody and complement in the lesion (biopsy) by immunofluorescence. Type III: Immune complex ( IgM, IgG) as GN:  Examination of tissue biopsies for deposits of immunoglobulin and complement by immunofluorescence microscopy.  The presence of immune complexes in serum and depletion in the level of complement are also diagnostic. Type IV : Cell mediated by T-lymphocytes (TB and contact dermatitis)  In vivo include delayed cutaneous reaction (e.g. Montoux test ).  In vitro tests for delayed hypersensitivity include assessment mitogenic response of T-lymphocytes and IL-2 production. Immunodeficiency Disease Classification:      Humoral immuno-deficiencies (B-cell immunodeficiency) Cellular immuno-deficiencies (T-cell immunodeficiency) Combined immuno-deficiencies Phagocytic immuno-deficiencies Complement immuno-deficiencies Cause of ID: - Genetic - Metabolic Deficiency - Vitamin Deficiency - Autoimmune Ds - Acquired secondary to infection, drugs, Radiation, cancer. Common clinical features of ID - Chronic infection - Recurrent infection - Unusual microbial agent - Incomplete clearing after infection 1-B-cell immunodeficiency diagnosis:  B-cell count (N.20-25% of lymphocytes)  B-cell functions:- Hypogamaglobulinaemia  Intact T-cell number and function 2  Selective IgA immunodeficiency: The commonest immunodeficiency. Only low IgA and normal another immunoglobulin and normal B-cell number. 2-T-cell immunodeficiency diagnosis:  T-cell count (N.70% of lymphocytes)  T-cell functions: Negative delayed hypersensitivity skin Mantoux test and IL2 production 3- Complement deficiency diagnosis:  Complement quantitation by Radial immunodiffussion 4- Phagocytic deficiency diagnosis :  Neutrophil count and phagocytosis test by Candida albicans killing test. Acquired immunodeficiency ds AIDS Cause:  HIV virus  Predilection to CD4 (helper)  defective immunity  Susceptible to a variety of infectious agents and certain tumors. Clinical features: Incubation 8-10 years Progress of ds Group I: acute 14 day (Mononucleosis –like syndrom) Group II: asymptomatic Group III: generalized lymph-adenopathy Group IV: AIDS a) Constitutional ds: fever, weight loss, diarrhea b) Neurological: dementia, neuropathy c) 2ry infections d) 2ry cancer as lymphoma and Kaposi sarcoma Diagnosis:     Early detection by detection of P24 Ag in blood Detection of HIV Ab ( 6-8 weeks) Lymphopenia (T helper) Decreased T cell function : as decreased delayed hypersensitivity response  HIV genome detection by PCR 3 Auto immune Ds  Self ag don’t induce lymphocyte stimulation, self tolerance.  Loss of self tolerance ( may be due to : Genetic, Cross reactive Ag, Alteration of Tc to Th cell ratio) results in auto immune ds Classification: A- Organ specific 1. Thyroid autoimmune dis B- Organ non specific 1. SLE 2- IDDM 3- Immune hemolytic anaemia 2- Rheumatoid arthritis I – Systemic Lupus Erythromatosis SLE Definition  Immune complex with consumption of C  Circulating Immune complex level correlates with ds SLE diagnosis : A-For diagnosis: 1-Serum ANA ( sensitive)…….Screening 2-Anti-DNA and Anti-Smith Ab (Specific)………diagnostic B- For activity ……ESR, C3,C4 and CIC C- For follow up…….Anti-DNA D- For follow up of organ involvement…..Hb, Platelets, Urine analysis , Kidney functions. II - Rheumatoid arthritis Diagnosis: A- Rheumatoid factor (75% patients) 1-Antiglobulin against Fc fragment of autologous IgG by Latex agglutination test 2-RF –ve don’t exclude R arthritis (Seronegative) and diagnosed by Anticycliccitrullinated peptides (Anti-CCP). are autoantibodies produced by the immune system that are directed against cycliccitrullinated peptides (CCP). B- CBC: NN anemia, high CRP & ESR C- Follow up: by CRP, ESR and not by RF titer. 4 III- Other autoimmune diseases: 1- Thyroid autoimmune diseases A- Hashimoto”s thyroidits diagnosis by: Detection of abs against thyroglobulin and thyroid microsomal Ag. B- Grave”s diseases diagnosis by: Detection of Anti-thyroid antibodies ( Thyroid stimulating immunoglobulin, Thyroid growth stimulating immunoglobulin, Thyroid binding inhibitory immunoglobulin). 2- Immune hemolytic anaemia - Diagnosed by Antiglobulin test ( Coomb”s test) - Pernicious anaemia by Anti-intrinsic factor Ab 3- IDDM: diagnosed by Detection of Anti-islet cell Ab early 4- Myasthenia Gravis by Anti-acetylcholin receptor Ab. 5- Autoimmune chronic hepatitis diagnosis 1- Liver function tests 2- Exclude of Viral hepatitis by viral marker 3- presence of one or more autoantibodies: - ANA - ASMA - Liver kidney microsomal ( LKM) - Soluble Liver Antigen 6- Primary Biliary Cirrhosis(PBC)  Liver function tests  Positive Anti-mitochondrial Ab( AMA) and this differentiate it from Primary sclerosing cholangitis ( -ve AMA) Tumor markers  Induced and Produced by tu cells  They are Released in blood or body fluids or are expressed on cell surfaces 1- tu derived: secreted by tu. 2- tu associated secreted as a result of the presence of the tu. Application:     Detection & screening in high risk population Diagnosis together with histo-pathologic studies Prognosis and staging , correlation to tu size Follow up 5 NB:     normal level does not exclude malignancy Single determination not definite Different markers combination Early indication of recurrence. it depends on change in tu marker conc. From recent base line  No tu marker is sensitive and specific enough to be used as screening test in an asymptomatic pt. Classification:       Hormones( as HCG in chriocarcinoma) Enzymes: ( as Acid phosphatase in cancer prostate) Proteins:(as Ig in multiple myloma) Tum: as in or Ag: as In following table Cell surface markers leukemias Metabolites: as Vanillyl mandelic acid in pheochromocytoma Breast Ovary Pancrease Liver Lung Stomach Colo-rectum Lymphoma Prostate Uterus Cervix Thyroid Leukaemia testis CA15.3 CA 125 Ca19-9 AFP CEA CEA CEA LDH PSA CEA CEA calcitonin B2M AFP CEA CEA CEA SCC-A CA72-4 CA19.9 ESR CA72-4 B2M CA125 CEA ferretin HCG 6 LDH Hepatitis B Hepatitis C 1. Biochemical test 1. Biochemical test Increased: ALT , AST, ALP , Mild elevation: ALT, AST, ALP, Bilirubin BIL 2. Serology 2. Serology a) HBs Ag: earliest, before symptoms a) Ab detection: IgG ELISA b) HBe Ag: , replication, - F-ve in early acute cases c) HBc Ab: - F+ve in autoimmune & RF early IgM (IgG for life), in window b) Viral RNA by PCR phase recent infection d)HBe Ab: conversion from Ag to Ab = good sign, no conversion from Ag to Ab = chronicity e)HBs Ab: past inf. + immunity 7

Use Quizgecko on...
Browser
Browser